Compare SUN & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUN | BAX |
|---|---|---|
| Founded | 1960 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 10.2B |
| IPO Year | 2012 | 1994 |
| Metric | SUN | BAX |
|---|---|---|
| Price | $67.74 | $17.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 9 |
| Target Price | ★ $68.33 | $21.00 |
| AVG Volume (30 Days) | 291.5K | ★ 6.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.57% | 0.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $25,201,000,000.00 | $11,244,000,000.00 |
| Revenue This Year | $63.67 | $1.96 |
| Revenue Next Year | $0.84 | $2.22 |
| P/E Ratio | $26.93 | ★ N/A |
| Revenue Growth | ★ 11.05 | 5.72 |
| 52 Week Low | $47.98 | $15.73 |
| 52 Week High | $67.82 | $32.68 |
| Indicator | SUN | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 62.88 | 40.92 |
| Support Level | $61.96 | $15.73 |
| Resistance Level | N/A | $18.97 |
| Average True Range (ATR) | 1.30 | 0.64 |
| MACD | 0.22 | 0.00 |
| Stochastic Oscillator | 92.19 | 4.83 |
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; Refinery and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.